Literature DB >> 12218602

Interpretation of fetal hemoglobin only on newborn screening for hemoglobinopathy.

Matthew M Heeney1, Kathleen Delgrosso, Robbi Robinson, Christine A Johnson, Charles W Daeschner, Thomas A Campbell, Saul Surrey, Russell E Ware.   

Abstract

Newborn screening for hemoglobinopathies rarely produces a fetal hemoglobin only result; it is most consistent with beta-thalassemia major, although other diagnoses are possible. The authors describe two unrelated African-American babies born in North Carolina whose newborn screening revealed fetal hemoglobin only. Both had a relatively benign clinical and hematologic picture. Molecular analyses indicated that both children are compound heterozygotes for beta-thalassemia and pancellular (deletional) hereditary persistence of fetal hemoglobin, a rare and apparently benign condition. Accurate interpretation of the fetal hemoglobin only result on newborn screening requires thorough evaluation, including family studies and molecular analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218602     DOI: 10.1097/00043426-200208000-00019

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.

Authors:  Venée N Tubman; Roseda Marshall; Wilhemina Jallah; Dongjing Guo; Clement Ma; Kwaku Ohene-Frempong; Wendy B London; Matthew M Heeney
Journal:  Pediatr Blood Cancer       Date:  2016-01-06       Impact factor: 3.167

2.  Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin.

Authors:  Urvashi Bhardwaj; Edward R B McCabe
Journal:  Mol Diagn       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.